Literature DB >> 10637491

Expression of Flt3-ligand by the endothelial cell.

A Solanilla1, C Grosset, C Lemercier, M Dupouy, F X Mahon, K Schweitzer, J Reiffers, B Weksler, J Ripoche.   

Abstract

Flt3-ligand (FL) is a cytokine that is of paramount importance in the proliferation of primitive hematopoietic progenitors. In this study, we show that endothelial cells (EC) produce large amounts of soluble FL and express a membrane-bound form of the molecule. Bone marrow microvascular EC also produce FL, suggesting that EC are an important source of FL in the bone marrow. High concentrations of FL in EC supernatants contrast with its undetectable levels in long-term bone marrow cultures. A single mRNA for FL is detected, suggesting that soluble FL derives from the membrane-bound species by proteolytic release. FL mRNA is stable with a half-life of about 3 h. II-1alpha increases FL mRNA levels and membrane and soluble FL expression. Glucocorticoids, known inhibitors for many hematopoietic growth factors do not down-regulate the expression of FL. On the contrary, GC increase the expression of both species of FL. The neutralization of FL in cocultures EC/ hematopoietic progenitors results in an acceleration of the maturation of the progenitors. IFN-alpha, MIP-1 alpha and TGF-beta stimulate production of membrane-bound and soluble FL. This stimulation is essential to explain their modulatory effect on the generation of clonogenic cells in cocultures EC/hematopoietic progenitors. Leukemia (2000) 14, 153-162.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637491     DOI: 10.1038/sj.leu.2401635

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 3.  Innate immune regulation by STAT-mediated transcriptional mechanisms.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

4.  A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

Authors:  Kevin C Barry; Joy Hsu; Miranda L Broz; Francisco J Cueto; Mikhail Binnewies; Alexis J Combes; Amanda E Nelson; Kimberly Loo; Raj Kumar; Michael D Rosenblum; Michael D Alvarado; Denise M Wolf; Dusan Bogunovic; Nina Bhardwaj; Adil I Daud; Patrick K Ha; William R Ryan; Joshua L Pollack; Bushra Samad; Saurabh Asthana; Vincent Chan; Matthew F Krummel
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

5.  Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.

Authors:  Rachel Mak'Anyengo; Peter Duewell; Cornelia Reichl; Christine Hörth; Hans-Anton Lehr; Sandra Fischer; Thomas Clavel; Gerald Denk; Simon Hohenester; Sebastian Kobold; Stefan Endres; Max Schnurr; Christian Bauer
Journal:  JCI Insight       Date:  2018-03-08

Review 6.  Targeting FLT3 to treat leukemia.

Authors:  Heiko Konig; Mark Levis
Journal:  Expert Opin Ther Targets       Date:  2014-09-18       Impact factor: 6.902

7.  A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).

Authors:  Pankaj Gupta; Flora Mulkey; Robert P Hasserjian; Ben L Sanford; Ravi Vij; David D Hurd; Olatoyosi M Odenike; Clara D Bloomfield; Kouros Owzar; Richard M Stone; Richard A Larson
Journal:  Invest New Drugs       Date:  2013-05-23       Impact factor: 3.850

8.  Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Florin Niculescu; Katherine M Mullen; Sonia Vlaicu; Susan I V Judge; Peter A Calabresi; Horea Rus
Journal:  Exp Mol Pathol       Date:  2007-07-06       Impact factor: 3.362

Review 9.  Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy.

Authors:  Harinder Gill; Anskar Y H Leung; Yok-Lam Kwong
Journal:  Int J Mol Sci       Date:  2016-03-24       Impact factor: 5.923

10.  Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.

Authors:  Hassan Y Ebrahim; Khalid A El Sayed
Journal:  Mar Drugs       Date:  2016-03-11       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.